Right atrial thrombosis in a patient with antiphospholipid syndrome and abnormal mesenchymal septum;Trombosi atriale destra in paziente con sindrome da anticorpi antifosfolipidi e setto anomalo mesenchimale

Italian Heart Journal Supplement

Volumn 2, Issue 10, 2001, Pages 1111-1116

  Ghirarduzzi, A ^a   Galimberti, D ^a   Silingardi, M ^a   Cerioli, G C ^a   Parravicini, R ^a   Salvarani, C ^a   Iori, I ^a  

^a NONE   (Italy)

Author keywords

Congenital heart disease; Echocardiography; Intracardiac thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; WARFARIN;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART RIGHT ATRIUM; HEMATOLOGICAL PARAMETERS; HUMAN; INTRACARDIAC THROMBOSIS; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HEART DISEASES; HEART SEPTAL DEFECTS; HUMANS; THROMBOSIS;

EID: 0035216975     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Primary, "secondary" and other variants of antiphospholipid syndrome
2. Antiphospholipid syndrome in the elderly: Caution
3. Towards improved criteria for the antiphospholipid syndrome
4. Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease. A case-control study
5. High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension
6. Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
7. Intracardiac thrombus in antiphospholipid syndrome
8. Intracardiac thrombi associated with antiphospholipid antibodies
9. Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography
10. Transesophageal echocardiographic diagnosis of right atrial thrombi associated with the antiphospholipid syndrome
11. Criteria for the diagnosis of lupus anticoagulants: An update
12. Comparison of test methods for the lupus anticoagulant: International Survey on Lupus Anticoagulants-1 (ISLA-1)
13. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay: Standardization and quantitation of results
14. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four year prospective study from the Italian registry
15. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile
16. Lupus anticoagulants and thrombosis: Clinical association of different coagulation and immunologic tests
17. Systemic lupus erythematosus and the antiphospholipid syndrome: Reflections about the relevance of ARA-criteria
18. The 1982 revised criteria for the classification of systemic lupus erythematosus
19. Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment
20. The management of thrombosis in the antiphospholipid antibody syndrome
21. Thrombolytic treatment of type A right atrial thrombi
22. Thrombolytic treatment of type A right atrial thrombi: Descriptions of three cases and review of the literature
23. Intracardiac mural thrombus mimicking atrial myxoma in the antiphospholipid syndrome
24. Myxoma and antiphospholipid antibody syndrome
25. Asymptomatic intracardiac thrombi and primary antiphospholipid syndrome
26. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies